The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis

J Neuroimmunol. 2018 Aug 15:321:66-71. doi: 10.1016/j.jneuroim.2018.05.015. Epub 2018 May 28.

Abstract

We tested the performance of MRZ-reaction, an intrathecal humoral immune response against-Measles (M), Rubella (R) and Varicella Zoster (Z) viruses, in multiple sclerosis (MS) diagnosis. The MRZ-reaction was significantly more positive in MS than in non-MS group with a specificity of 91.9%. In MS group, the RZ-profile was the most prevalent and the R-specific antibody-index was correlated to the number of oligoclonal bands (OCB) in CSF. Interestingly, the MRZ-reaction was detected in 53% of OCB-negative-MS patients. The MRZ-reaction seems to be a relevant CSF diagnostic marker of MS disease. The likely relation between its positivity and the vaccination status deserves to be investigated.

Keywords: Intrathecal humoral immune response; MRZ reaction; Measles; Multiple sclerosis; Rubella; Varicella zoster virus.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Biomarkers / cerebrospinal fluid
  • Female
  • Herpesvirus 3, Human / isolation & purification
  • Herpesvirus 3, Human / metabolism*
  • Humans
  • Immunity, Humoral / physiology*
  • Male
  • Measles virus / isolation & purification
  • Measles virus / metabolism*
  • Middle Aged
  • Multiple Sclerosis / cerebrospinal fluid*
  • Multiple Sclerosis / diagnosis*
  • Rubella virus / isolation & purification
  • Rubella virus / metabolism*
  • Young Adult

Substances

  • Biomarkers